Biogen stock rises as Novo Nordisk's Alzheimer's trials disappoint, spotlighting Leqembi's role and a new immunology collaboration with Dayra Therapeutics.
Trump prepares a health care plan proposing an ACA subsidy extension, new eligibility caps and measures to counter premium spikes as year-end deadlines approach.